homocysteine has been researched along with Wet Macular Degeneration in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García, JB; Piñero, DP; Rodrigo, F; Ruiz-Moreno, JM; Segura, JV; Torregrosa, ME | 1 |
| Blasetti, F; Carru, C; Castiglia, P; Pinna, A; Tendas, D; Zinellu, A | 1 |
| Losada, M; Manresa, N; Mulero, J; Zafrilla, P | 2 |
4 other study(ies) available for homocysteine and Wet Macular Degeneration
| Article | Year |
|---|---|
Color Doppler imaging of the retrobulbar circulation and plasmatic biomarkers of vascular risk in age-related macular degeneration: A pilot study.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Circulation; C-Reactive Protein; Ciliary Arteries; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Ophthalmic Artery; Orbit; Pilot Projects; Retinal Artery; Severity of Illness Index; Ultrasonography, Doppler, Color; Vitamin B 12; Wet Macular Degeneration | 2018 |
Plasma Homocysteine and Asymmetrical Dimethyl-l-Arginine (ADMA) and Whole Blood DNA Methylation in Early and Neovascular Age-Related Macular Degeneration: A Pilot Study.
Topics: Aged; Aged, 80 and over; Arginine; Case-Control Studies; DNA; DNA Methylation; Female; Homocysteine; Humans; Male; Pilot Projects; Risk Factors; Wet Macular Degeneration | 2016 |
Influence of anti-VEGF about cardiovascular biomarkers in age related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Atherosclerosis; Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Female; Fibrinogen; Homocysteine; Humans; Lipids; Macular Degeneration; Male; Middle Aged; Ranibizumab; Risk Factors; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2015 |
EFFECT OF PEGAPTANIB AND RANIBIZUMAB ON PLASMA AND VITREOUS HOMOCYSTEINE IN PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Aptamers, Nucleotide; Exudates and Transudates; Female; Homocysteine; Humans; Intravitreal Injections; Male; Middle Aged; Nephelometry and Turbidimetry; Ranibizumab; Vascular Endothelial Growth Factor A; Vitreous Body; Wet Macular Degeneration | 2015 |